Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice

Experimental Neurology

Volumn 204, Issue 1, 2007, Pages 411-420

  David, Gavriel ^a   Nguyen, Khanh ^a   Barrett, Ellen F ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; FAST MUSCLE; HINDLIMB; IN VIVO STUDY; MALE; MOTONEURON; MOUSE; MUSCLE ISCHEMIA; NERVE CELL NECROSIS; NERVE ENDING; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; REPERFUSION INJURY; SCIATIC NERVE; SLOW MUSCLE; SOLEUS MUSCLE; TOURNIQUET; WILD TYPE;

ADENINE; ANIMALS; DENERVATION; GENETIC PREDISPOSITION TO DISEASE; GUANINE; HINDLIMB; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR ENDPLATE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; MUTATION; NERVE ENDINGS; NERVE REGENERATION; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 33847259661     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.12.021     Document Type: Article

References (51)

1. Annex B.H., Torgan C.E., Lin P., Taylor D.A., Thompson M.A., Peters K.G., and Kraus W.E. Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am. J. Physiol.: Heart Circ. Physiol. 274 (1998) H860-H867
2. Atkin J.D., Scott R.L., West J.M., Lopes E., Quah A.K., and Cheema S.S. Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul. Disord. 15 (2005) 377-388
3. Azzouz M., Leclerc N., Gurney M., Warter J.M., Poindron P., and Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve 20 (1997) 45-51
4. Bevan S., and Steinbach J.H. Denervation increases the degradation rate of acetylcholine receptors at end-plates in vivo and in vitro. J. Physiol. 336 (1983) 159-177
5. Boillée S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., and Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
6. Bramlett H.M. Sex differences and the effect of hormonal therapy on ischemic brain injury. Pathophysiology 12 (2005) 17-27
7. Brown M.C., and Ironton R. Sprouting and regression of neuromuscular synapses in partially denervated mammalian muscles. J. Physiol. 278 (1978) 325-348
8. Brown M.C., Holland R.L., and Ironton R. Nodal and terminal sprouting from motor nerves in fast and slow muscles of the mouse. J. Physiol. 306 (1980) 493-510
9. Burke R.E. The structure and function of motor units. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology. 3rd ed. (2004), McGraw-Hill, New York 104-118
10. 2 release during aging in oxidative and glycolytic muscles in rats. Mech. Ageing Dev. 125 (2004) 367-373
11. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.A., Prattis S.M., and Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6 (1995) 349-362
12. Derave W., Van Den Bosch L., Lemmens G., Eijnde B.O., Robberecht W., and Hespel P. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol. Dis. 13 (2003) 264-272
13. Eastlack R.K., Groppo E.R., Hargens A.R., and Pedowitz R.A. Ischemia/reperfusion works on the NMJ rather than muscle, and there is no protection by ischemic preconditioning. J. Orthop. Res. 22 (2004) 918-923
14. Fahim M.S., Holley J.A., and Robbins N. Topographic comparison of neuromuscular junctions in mouse slow and fast twitch muscles. Neuroscience 13 (1984) 227-235
15. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2004) 232-240
16. Frey D., Schneider C., Xu L., Borg J., Spooren W., and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20 (2000) 2534-2542
17. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., and Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26 (2006) 8774-8786
18. Grozdanovic Z. NO message from muscle. Microsc. Res. Tech. 55 (2001) 148-153
19. Hegedus, J., Putman, C.T., Gordon, T., 2006. Activity-dependent conversion saves motor units (MUs) in a transgenic mouse model of amyotrophic lateral sclerosis (ALS) Program No. 823.10. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for Neuroscience. Online.
20. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., and Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 (2003) 839-842
21. Kennel P.F., Finiels F., Revah R., and Mallet J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. NeuroReport 7 (1996) 1427-1431
22. Kirkinezos I.G., Hernandez D., Bradley W.G., and Moraes C.T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 53 (2003) 804-807
23. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18 (1998) 3241-3250
24. LaFuste, P., Lambrechts, D., Poesen, K., Zacchigna, S., Storkebaum, E., Chevron, P., Demol, M., Collen, D., Giacca, M., Moons, L., Carmeliet, P., 2006. Role of VEGF in axon sprouting and neuromuscular junction innervation: relevance for ALS. Program No. 673.5, 2006 Neuroscience Meeting Planner. Atlanta, GA: Society from Neuroscience. Online.
25. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., and Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34 (2003) 383-394
26. Li W., Brakefield D., Pan Y., Hunter D., Myckatyn T.M., and Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp. Neurol. (2006) [electronic publication ahead of print]
27. Luedeke J.D., McCall R.D., Dillaman R.M., and Kinsey S.T. Properties of slow- and fast-twitch skeletal muscle from mice with an inherited capacity for hypoxic exercise. Comp. Biochem. Physiol., A Mol. Integr. Physiol. 138 (2004) 373-382
28. Mahoney D.J., Rodriguez C., Devries M., Yaasuda N., and Tarnopolsky M.A. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 29 (2004) 656-662
29. Mahoney D.J., Kaczor J.J., Bourgeois J., Yasuda N., and Tarnopolsky M.A. Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle Nerve 33 (2006) 809-816
30. Makitie J., and Teravainen H. Ultrastructure of striated muscle of the rat after temporary ischemia. Acta Neuropathol. (Berl.) 37 (1977) 237-245
31. Mariotti R., Cristino L., Bressan C., Boscolo S., and Bentivoglio M. Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis. Neuroscience 115 (2002) 331-335
32. Miana-Mena F.J., Muòoz M.J., Yagûe G., Mendez M., Morena M., Ciriza J., Zaragosa P., and Osta R. Optimal methods to characterize the G93A mouse model of ALS. Amyotraoph. Lateral Scler. 6 (2005) 55-62
33. Murakami T., Ilieva H., Shiote M., Nagata T., Nagano I., Shoji M., and Abe K. Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene. Brain Res. 989 (2003) 231-237
34. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckz V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckz F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28 (2001) 131-138
35. Pun S., Santos A.F., Saxena S., Xu L., and Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9 (2006) 408-419
36. Raoul C., Estévez A.G., Nishimune H., Cleveland D.W., DeLapeyrière O., Henderson C.E., Haase G., and Pettmann B. Motoneuron death triggered by a specific pathway downstream of fas: potentiation by ALS-linked SOD1 mutations. Neuron 35 (2002) 1067-1083
37. Raoul C., Buhler E., Sadeghi C., Jacquier A., Aebischer P., Pettman B., Henderson C.E., and Haase G. Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx and FasL. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6007-6012
38. Rich M.M., Waldeck R.F., Cork L.C., Balice-Gordon R.J., Fyffe R.E., Wang X., Cope T.C., and Pinter M.J. Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease. J. Neurophysiol. 88 (2002) 3293-3304
39. Sampei K., Mandir A.S., Asano Y., Wong P.C., Traystman R.J., Dawson V.L., Dawson T.M., and Hurn P.D. Stroke outcome in double-mutant antioxidant transgenic mice. Stroke 31 (2000) 2685-2691
40. Sasaki S., Warita H., Murakami T., Abe K., and Iwata M. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 107 (2004) 461-474
41. Schaefer A.M., Sanes J.R., and Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490 (2005) 209-219
42. Sharp P.S., Dick J.R., and Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 130 (2005) 897-910
43. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., Wyns S., Manka D., Vermeulen K., Van Den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E.M., Collen D., Moons L., and Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8 (2005) 85-92
44. Tombol T., Pataki G., Nemeth A., and Hamar J. Ultrastructural changes of the neuromuscular junction in reperfusion injury. Cells Tissues Organs 170 (2002) 139-150
45. Totsuka Y., Nagao Y., Horii T., Yonekawa H., Imai H., Hatta H., Izaike Y., Tokunaga T., and Atomi Y. Physical performance and soleus muscle fiber composition in wild-derived and laboratory inbred mouse strains. J. Appl. Physiol. 95 (2003) 720-727
46. Veldink J.H., Bar P.R., Joosten E.A., Otten M., Wokke J.H., and Van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13 (2003) 737-743
47. 2+] elevations in mouse motor terminals: comparison of wild-type with SOD1-G93A. J. Physiol. 549 (2003) 719-728
48. Waters R.E., Rotevatn S., Li P., Annex B.H., and Yan Z. Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am. J. Physiol.: Cell Physiol. 287 (2004) C1342-C1348
49. Wooley C.M., Sher R.B., Kale A., Frankel W.N., Cox G.A., and Seburn K.L. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32 (2005) 43-50
50. Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., and Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5709-5714
51. Yim M.B., Yim H.S., Chock P.B., and Stadtman E.R. Enhanced free radical generation of FALS-associated Cu, Zn-SOD mutants. Neurotox. Res. 1 (1999) 91-97